This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Lee, J Y-Y Articles by Deng, J-S Search for Related Content PubMed PubMed Citation Articles by Lee, J Y-Y Articles by Deng, J-S Social Bookmarking                         What's this?

Anti-adenosine deaminase antibodies in lupus erythematosus

Department of Dermatology, National Cheng-Kung University, Taiwan, Republic of China

J Hempel

Department of Biological Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania, USA

J-S Deng

Department of Dermatology, University of Pittsburgh and VAMC, Department of Veterans Affairs Medical Center, University Drive C, Pittsburgh, PA 15240, USA. Jdeng{at}imap.pitt.edu

Adenosine deaminase (ADA) is an enzyme involved in purine metabolism and has a major role in the development and function of lymphoid cells. Congenital de" ciency of ADA results in severe immunode"ciency. Patients with congenital ADA de" ciency treated with polyethylene glycolconjugated bovine ADA develop antibodies to ADA. This leads us to investigate the role of antiADA antibodies in patients with systemic rheumatic diseases. Commercially available ADA was used in ELISA and immunoblots for detection of anti-ADA antibodies. Four out of 100 patients examined were positive for anti-ADA antibodies. Two of them had peripheral blood lymphopenia but the antibody levels did not appear to correlate with the lymphocyte counts. Immunoblotting revealed that the antibodies recognized a 40 kDa peptide of ADA, corresponding to ADA1, the major component of ADA. Af" nity-puri"ed antibodies were used to locate the distribution of ADA on Hep-2 cells and lymphocytes by indirect immuno‘ uorescence. Anti-ADA antibodies gave a distinct nuclear speckled pattern on acetone-"xed cells. With viable cell immuno‘ uorescence, antiADA antibodies also stained the cell surface of HEp-2 cells and lymphocytes, indicating surface expression of ADA. The anti-ADA antibodies failed to gain access into the cytoplasm or nuclei when added to the cultures of HEp-2 cells. In summary, this is the " rst report of detection of antiADA1 autoantibody which is a new type of ANA with discrete, speckled nuclear staining, but which may not be associated with lymphopenia.

Key Words: adenosine deaminase • lupus erythematosus

Lupus, Vol. 11, No. 3, 168-174 (2002)
DOI: 10.1191/0961203302lu162oa


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				O. Ozdemir, E. Lainka, T. Niehues, and M. Hershfield Increasing Importance of Stem Cell Gene Therapy in Adenosine Deaminase Deficiency? Clin. Vaccine Immunol., March 1, 2006; 13(3): 433 - 435. [Full Text] [PDF]